
Loading, please wait...

Loading, please wait...

Clinicians managing neonatal asphyxia face significant challenges when assessing long-term neurological prognosis. Consequently, identifying reliable biomarkers during the early hours of life is essential for guiding clinical decisions and parental counseling. A recent secondary analysis published in Acta Paediatrica suggests that combining biochemical and neurophysiological markers significantly enhances HIE outcome prediction in transported newborns.
The study evaluated 113 asphyxiated infants who required transport for therapeutic hypothermia. Researchers analyzed lactate dehydrogenase (LDH) levels and amplitude-integrated electroencephalography (aEEG) readings obtained within the first 12 hours of life. Specifically, they defined poor outcomes at 18 months as moderate to severe impairment or death. The findings indicate that these bedside tools offer robust prognostic value even before reaching a tertiary care center.
The analysis revealed that LDH levels exceeding 1000 U/L predicted poor outcomes with 89% sensitivity and 61% specificity. Furthermore, a severely depressed aEEG background within the first 12 hours demonstrated 87% sensitivity. However, the most compelling results emerged when clinicians combined both markers. This integrated approach achieved a sensitivity of 91% and an overall accuracy of 81% for HIE outcome prediction.
Additionally, the research noted that while rectal temperatures varied between different cooling methods during transport, the overall clinical characteristics and outcomes remained similar. Therefore, the predictive power of LDH and aEEG appears consistent regardless of the specific transport cooling device used. This combination provides a practical, low-cost strategy for early risk stratification in encephalopathic infants.
Implementing these markers early in the transport phase allows for timely communication with families. Moreover, it assists neonatologists in identifying which infants may require more intensive monitoring or specialized interventions. Ultimately, the use of LDH and aEEG represents a significant step toward objective and reproducible prognostic assessments in neonatal intensive care units.
LDH acts as a marker of systemic and tissue injury following hypoxia. High levels, specifically above 1000 U/L, correlate with more severe brain injury and poorer neurodevelopmental outcomes at 18 months.
aEEG provides a continuous assessment of electrocortical background activity. A severely depressed pattern early in life indicates significant cerebral dysfunction, which is a strong predictor of long-term impairment.
According to the study, while different cooling methods (like phase-change material mattresses) may result in different admission temperatures, they do not significantly alter the predictive accuracy of LDH or aEEG.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Tran HTT et al. Early Prediction of Outcome Using Lactate Dehydrogenase and Amplitude-Integrated EEG in Transported Newborn Infants with Hypoxic-Ischaemic Encephalopathy. Acta Paediatr. 2026 Apr 30. doi: 10.1111/apa.70556. PMID: 42059139.
2. Karlsson M, Blennow M, Nemeth A, Dahlin I. Lactate dehydrogenase predicts hypoxic ischaemic encephalopathy in newborn infants: a preliminary study. Acta Paediatr. 2010;99(8):1139-1144.
3. Ouwehand S, Smidt A, Dudink J, et al. Predictors of outcomes in hypoxic-ischemic encephalopathy following hypothermia: a meta-analysis. Scientific Reports. 2020;10(1):4179.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research highlights how combining early LDH levels and aEEG readings provides an 81% accuracy rate in predicting outcomes for infants with HIE....
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today